Publication:
Clinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iran

dc.contributor.authorKord, Mohammad
dc.contributor.authorSalehi, Mohammadreza
dc.contributor.authorHashemi, Seyed Jamal
dc.contributor.authorAbdollahi, Alireza
dc.contributor.authorAlijani, Neda
dc.contributor.authorMaleki, Ayda
dc.contributor.authorMahmoudi, Shahram
dc.contributor.authorAhmadikia, Kazem
dc.contributor.authorParsameher, Nasrin
dc.contributor.authorMoradi, Masoud
dc.contributor.authorAbdorahimi, Mahsa
dc.contributor.authorRezaie, Sara
dc.contributor.authorHashemi Fesharaki, Shirin Sadat
dc.contributor.authorAbbasi, Kiana
dc.contributor.authorAlcazar-Fuoli, Laura
dc.contributor.authorKhodavaisy, Sadegh
dc.contributor.funderTehran University of Medical Sciences (Irán)
dc.date.accessioned2023-05-08T07:48:09Z
dc.date.available2023-05-08T07:48:09Z
dc.date.issued2022-09
dc.description.abstractBackground and purpose: Candidemia is a major cause of morbidity and mortality among patients receiving immunosuppressive therapy and those hospitalized with serious underlying diseases. Here, we investigated the epidemiological, clinical, and mycological features of candidemia in Tehran, Iran. Materials and methods: A prospective observational study of all patients diagnosed with candidemia was performed at two referral teaching hospitals in Tehran, Iran, from February to December 2018. Demographic characteristics, underlying diseases, risk factors, clinical symptoms, and laboratory analyses of candidemic patients with positive culture were mined. Candida isolates were molecularly identified by sequencing of the internal transcribed spacer region (ITS1-5.8S-ITS2). The antifungal susceptibility testing for fluconazole, itraconazole, voriconazole, posaconazole, amphotericin B, caspofungin, micafungin, and anidulafungin against the isolates was performed using CLSI broth microdilution reference method (M27-A3). Results: A total of 89 episodes were identified, with an incidence of 2.1 episodes/1000 admissions. The common underling disease were malignancy (46%), renal failure/dialysis (44%), and hypertension (40%). The overall crude mortality was 47%. C. albicans (44%) was the most frequent causative agent, followed by C. glabrata (21%), C. parapsilosis complex (15%), C. tropicalis (11%), and C. lusitaniae (3.5%). All the isolates were susceptible to amphotericin B. The activity of all four azoles was low against non-albicans Candida species, especially C. tropicalis. Conclusion: The increase in non-albicans Candida species with reduced susceptibility to antifungal drugs might be alarming in high-risk patients. Therefore, accurate knowledge of predisposing factors and epidemiological patterns in candidemia are effective steps for managing and decreasing the mortality rate in candidemia.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipThis study has been funded and supported by Tehran University of Medical Sciences, Tehran, Iran (Grant no. 99-2-99-48944).es_ES
dc.format.number3es_ES
dc.format.page9-17es_ES
dc.format.volume8es_ES
dc.identifier.citationCurr Med Mycol. 2022 Sep;8(3):9-17.es_ES
dc.identifier.doi10.18502/cmm.8.3.11207es_ES
dc.identifier.issn2423-3439es_ES
dc.identifier.journalCurrent medical mycologyes_ES
dc.identifier.pubmedID37051552es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16005
dc.language.isoenges_ES
dc.publisherMazandaran University of Medical Sciences (Irán)es_ES
dc.relation.publisherversionhttps://doi.org/10.18502/cmm.8.3.11207es_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectAntifungal susceptibilityes_ES
dc.subjectCandidemiaes_ES
dc.subjectEpidemiologyes_ES
dc.subjectIranes_ES
dc.subjectRisk factorses_ES
dc.titleClinical, epidemiological, and mycological features of patients with candidemia: Experience in two tertiary referral centers in Iranes_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublicationedbfddd9-077c-48b7-aa3a-9e3414469c6e
relation.isAuthorOfPublication.latestForDiscoveryedbfddd9-077c-48b7-aa3a-9e3414469c6e
relation.isFunderOfPublication7cfc3e86-e698-4cd0-ab60-4acc40d17dc5
relation.isFunderOfPublication.latestForDiscovery7cfc3e86-e698-4cd0-ab60-4acc40d17dc5

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ClinicalEpidemiologicalMycologicalFeatures_2022.pdf
Size:
804.27 KB
Format:
Adobe Portable Document Format
Description: